Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients

NACompletedINTERVENTIONAL
Enrollment

293

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
SchizophreniaMood DisordersSubstance Dependence
Interventions
BEHAVIORAL

Behavioral Treatment for Substance Abuse in SPMI (BTSAS)

Multifaceted treatment for substance abuse in dual disordered patients which contains 6 components: 1) a urinalysis contingency to enhance motivation to change and increase the salience of goals; 2) structured goal setting to identify realistic, short term goals for decreased substance use; 3) motivational interviewing to enhance motivation to reduce use; 4) social skills and drug refusal skills to enable development of relationships with people who do not use drugs, and to provide success experiences that can increase self-efficacy for change; 5) education about the reasons for substance use and the particular dangers of substance use for people with SPMI; and 6) relapse prevention training that focuses on behavioral skills for coping with urges and dealing with high risk situations and lapses. BTSAS is specifically structured to reduce the load on memory and attention, and minimize demands on higher level cognitive processes.

BEHAVIORAL

Supportive Treatment in Addiction Recovery (STAR)

Manualized substance abuse treatment as usual

BEHAVIORAL

Critical Time Intervention (CTI)

Case management component

Trial Locations (4)

21201

Health Care for the Homeless, Baltimore

University of Maryland, Baltimore, Baltimore

VA Maryland Health Care System, Baltimore

21228

Mosaic Community Services, Catonsville

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT00295139 - Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients | Biotech Hunter | Biotech Hunter